These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 15185321)
81. Genetic determinants of hepatic steatosis in man. Hooper AJ; Adams LA; Burnett JR J Lipid Res; 2011 Apr; 52(4):593-617. PubMed ID: 21245030 [TBL] [Abstract][Full Text] [Related]
82. Relative contribution of iron burden, HFE mutations, and insulin resistance to fibrosis in nonalcoholic fatty liver. Bugianesi E; Manzini P; D'Antico S; Vanni E; Longo F; Leone N; Massarenti P; Piga A; Marchesini G; Rizzetto M Hepatology; 2004 Jan; 39(1):179-87. PubMed ID: 14752836 [TBL] [Abstract][Full Text] [Related]
83. Increased susceptibility to nonalcoholic fatty liver disease in heterozygotes for the mutation responsible for hereditary hemochromatosis. Valenti L; Dongiovanni P; Fracanzani AL; Santorelli G; Fatta E; Bertelli C; Taioli E; Fiorelli G; Fargion S Dig Liver Dis; 2003 Mar; 35(3):172-8. PubMed ID: 12779071 [TBL] [Abstract][Full Text] [Related]
84. Nash, insulin resistance and iron. Machado M; Cortez-Pinto H Liver Int; 2006 Dec; 26(10):1159-62. PubMed ID: 17105580 [No Abstract] [Full Text] [Related]
85. Iron and HFE mutations in nonalcoholic steatohepatitis: innocent bystanders or accessories to the crime? Bhattacharya R; Kowdley KV Gastroenterology; 2003 Aug; 125(2):615-6; discussion 617. PubMed ID: 12891567 [No Abstract] [Full Text] [Related]
86. Relative contribution of iron burden, HFE mutations, and insulin resistance to fibrosis in nonalcoholic fatty liver. Loria P; Lonardo A; Carulli N Hepatology; 2004 Jun; 39(6):1748; author reply 1749. PubMed ID: 15185321 [No Abstract] [Full Text] [Related]
87. Iron overload and chronic hepatitis C: the role of HFE gene mutations. García Buey L; González Mateos F Rev Esp Enferm Dig; 2003 Dec; 95(12):819-28. PubMed ID: 14972003 [No Abstract] [Full Text] [Related]
88. [Iron in the era of molecular biology]. Deugnier Y; Moirand R; Brissot P; David V Pathol Biol (Paris); 1999 Nov; 47(9):938-44. PubMed ID: 10609274 [TBL] [Abstract][Full Text] [Related]
89. Iron as a co-morbid factor in nonhemochromatotic liver disease. Bonkovsky HL; Lambrecht RW; Shan Y Alcohol; 2003 Jun; 30(2):137-44. PubMed ID: 12957298 [TBL] [Abstract][Full Text] [Related]
90. [Involvement and role of iron in nonalcoholic steatohepatitis]. Cojocariu C; Trifan A; Stanciu C Rev Med Chir Soc Med Nat Iasi; 2008; 112(2):308-12. PubMed ID: 19294996 [TBL] [Abstract][Full Text] [Related]
91. Iron, the HFE gene, and hepatitis C. Eisenbach C; Gehrke SG; Stremmel W Clin Liver Dis; 2004 Nov; 8(4):775-85, vii-viii. PubMed ID: 15464655 [TBL] [Abstract][Full Text] [Related]
92. Pathology of hepatic iron overload. Deugnier Y; Turlin B World J Gastroenterol; 2007 Sep; 13(35):4755-60. PubMed ID: 17729397 [TBL] [Abstract][Full Text] [Related]
93. Commentary on "The overlapping of local iron overload and HFE mutation in venous leg ulcer pathogenesis". Zacharski LR; Engman CA Free Radic Biol Med; 2006 May; 40(10):1700-1. PubMed ID: 16678009 [No Abstract] [Full Text] [Related]
94. Risk of iron overload in carriers of genetic mutations associated with hereditary haemochromatosis: UK Food Standards Agency workshop. Singh M; Ashwell M; Sanderson P; Cade J; Moreton J; Fairweather-Tait S; Roe M; Marx JJ; Worwood M; Cook JD Br J Nutr; 2006 Oct; 96(4):770-3. PubMed ID: 17010238 [TBL] [Abstract][Full Text] [Related]